Baylor Genetics

Unlocking the Power of Precision Diagnostics for Neurological Disorders

Complex neurologic conditions often require a deeper view of disease biology to uncover their underlying genetic cause. Baylor Genetics’ flagship multimodal Whole Genome Sequencing (WGS) solution combines comprehensive genomic analysis with complementary testing technologies and advanced interpretation to provide clinicians with a more complete view of genetic disease.

By taking this broader approach to testing, our goal is to deliver more answers for patients with complex neurodevelopmental and neurologic disorders, helping clinicians resolve challenging cases, shorten the diagnostic odyssey, and guide patient management.

In addition to multimodal WGS, Baylor Genetics offers Whole Exome Sequencing (WES) and a comprehensive 236-gene Neurodevelopmental Disorders Panel to support the diagnosis of developmental delay (DD), intellectual disability (ID), epilepsy, and other neurologic conditions. Our goal is to help clinicians shorten the diagnostic odyssey and deliver answers that improve patient care.

Comprehensive Testing Options

Baylor Genetics offers a portfolio of testing solutions to support the evaluation of patients with suspected neurodevelopmental and neurologic disorders. 

• Multimodal Whole Genome Sequencing (WGS): Our most comprehensive genomic test, integrating complementary technologies and advanced interpretation to evaluate a broad range of genetic variation.  

• Whole Exome Sequencing (WES): Comprehensive analysis of the protein-coding regions of the genome for patients with suspected genetic disease.  

• Neurodevelopmental Disorders Panel: A 236-gene panel designed for patients with suspected or clinically diagnosed neurodevelopmental disorders, including developmental delay (DD) and intellectual disability (ID).

On-Demand Webinar

[Webinar]: Navigating Uncertainty: Next Steps in the Diagnostic Odyssey for Pediatric Patients

[Video] How Whole Genome Sequencing is Transforming Neurodevelopmental Care 

[Webinar] Genomic Testing for Child Neurology 

Content Library

[White paper]: From Instability to Insight: Genome Sequencing as a Tool for Diagnosing Pediatric Ataxias

[White paper] The Utility of Whole Genome Sequencing for Patients with Neurodevelopmental Disorders 

The Utility of Genome Sequencing as a Diagnostic Tool for Children with Ataxia 

Expanding the Genotypic Spectrum for ReNU Syndrome: A Clinical Laboratory Experience 

Multiomic and Multimodal Technologies to Support Rare Disease Diagnostics

The Clinical and Genetic Landscape of Epilepsy in Individuals with Dual Diagnoses 

The Diagnostic Yield of Whole Genome Sequencing for Patients with Epilepsy 

Diagnostic Yield of Whole Genome Sequencing for Patients with Neurodevelopmental Delays